Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

Therapeutic drug monitoring (TDM) in cancer, while imperative, has been challenging due to inter-patient variability in drug pharmacokinetics. Additionally, most pharmacokinetic monitoring is done by assessments of the drugs in plasma, which is not an accurate gauge for drug concentrations in target...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Mol Biosci
Autores principales: Shah, Jay V., Gonda, Amber, Pemmaraju, Rahul, Subash, Aishwarya, Bobadilla Mendez, Carolina, Berger, Marissa, Zhao, Xinyu, He, Shuqing, Riman, Richard E., Tan, Mei Chee, Pierce, Mark C., Moghe, Prabhas V., Ganapathy, Vidya
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7575924/
https://ncbi.nlm.nih.gov/pubmed/33134314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.569415
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares